Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/34333| Title: | Assessing Response for Nivolumab Plus Ipilimumab in Squamous Cell Carcinoma of the Head and Neck. | Austin Authors: | Klein, Oliver | Affiliation: | Olivia Newton-John Cancer Research Institute | Issue Date: | 1-Jan-2024 | Date: | 2023 | Publication information: | JAMA Oncology 2024-01-01; 10(1) | URI: | https://ahro.austin.org.au/austinjspui/handle/1/34333 | DOI: | 10.1001/jamaoncol.2023.5404 | ORCID: | Journal: | JAMA Oncology | PubMed URL: | 37991743 | ISSN: | 2374-2445 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.